Oral Antiseptics for Senior Citizens: Meeting the Needs of an Aging Population By 2022 to 2028

BySanket Badgujar
Market Research

The Oral antiseptics Market are anticipated to generate a market value of US$ 2.47 billion by 2022. From 2022 to 2028, oral antiseptic sales are projected to increase at a CAGR of 4.7% and reach a market value of US$ 3.24 billion.

By the end of 2018, oral antiseptics had generated sales of US$ 2 billion, according to a recent study by Future Market Insights. By the end of 2019, a mild 4.3% sales rise is anticipated. According to the survey, the European market accounts for about 30% of global value share, while North American and East Asian markets are experiencing more promising growth prospects.

Request a Report Sample to Gain Comprehensive Insights @
https://www.futuremarketinsights.com/reports/sample/rep-gb-8871

The key thrust factors driving the revenue growth of the oral antiseptics market will continue to be the rising use of mouthwash and oral antiseptics, as well as the expanding availability of new and niche products in the oral antiseptics category. The market for oral antiseptics is steadily growing as a result of rising recommendations from general dentists, solo and group practitioners, and dental research laboratories, all of which are firmly supported by regional and international brands’ successful marketing tactics.

Oral antiseptics are preferred to mouthwash by three out of every ten Europeans. Although oral antiseptics market participants have found that Europe has the greatest consumer base, rising per capita consumption is anticipated for the East Asian and North American consumer bases. Over 42% of oral antiseptic sales, or the majority, are centred in supermarkets and hypermarkets. However, FMI predicts that in the upcoming years, a scenario of increasing demand would emerge in the market for drug stores.

Herbal oral antiseptics to rise on the back of chemical-based products:

Cetylpyridinium chloride-based oral antiseptics, the bestseller over the years, will maintain a dominant value share in the market. While almost 75% of the total sales is accounted by Cetylpyridinium chloride-based oral antiseptics, a negligible share is currently contributed by the herbal segment. However, herbals are likely to emerge attractive in the long run.

In line with the concerns related to possible discomfort and side effects of strong oral antiseptics that typically include alcohol and a few other chemical components, herbal products are launched in oral antiseptics market as a milder and safer alternative to chemical-based oral antiseptics. FMI opines that alcohol-free, organic, and Ayurvedic products will particularly witness strong demand in the herbal oral antiseptics category. Relatively low competitiveness of the herbal segment operated by a lesser number of players is expected to create scope of growth for oral antiseptics market.

A visibly rising trend of strategic collaborations between major brands in oral antiseptics space is translating into an expanded consumer base of collaborating entities. The report further states that mergers and acquisitions are not only limited to industry giants but also involve a large number of regional players that are potential acquisitions candidates for MNCs. This according to the report will result in a more consolidated competition landscape in the global oral antiseptics market. Within the course of past two years, Henry Schein Inc. has accomplished eight acquisition deals traversing multiple verticals in the dental healthcare realm.

Key Companies Profiled:

  • Procter & Gamble
  • Revive Personal Products Company
  • 3M
  • Colgate-Palmolive
  • Johnson & Johnson
  • Dentaid SL
  • ICPA Health Products
  • Cipla Inc.
  • Church & Dwight Inc.
  • Dentsply Sirona

Key Segments of Oral Antiseptics Industry Survey

Oral Antiseptics Market by Product Type:

  • Cetylpyridinium Chloride-based Oral Antiseptics
  • Chlorhexidine Gluconate-based Oral Antiseptics
  • Herbal Oral Antiseptics
  • Essential Oils

Oral Antiseptics Market by Distribution Channel:

  • Oral Antiseptics Sold at Supermarkets/Hypermarkets
  • Oral Antiseptics Sold at Drug Stores
  • Oral Antiseptics Sold at Retail Pharmacies
  • Oral Antiseptics Sold through e-Commerce